We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UI:NYSEUbiquiti Inc. Analysis

Data as of 2026-03-15 - not real-time

$759.84

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Ubiquiti Inc. (UI) is trading well above its 20‑day, 50‑day and 200‑day simple moving averages at $759.84, indicating a strong bullish price bias. The RSI of 58 suggests momentum remains in the upside zone, yet the MACD histogram is negative and the MACD signal is flagged as bearish, hinting at a possible short‑term weakening. Volume has been trending down, and the stock faces a clear resistance near $803 while support sits around $688, framing a relatively tight trading range. Fundamentally, the company posted 35.8% revenue growth, robust operating margins above 35%, and a solid free cash flow generation of $517 M. However, its valuation multiples are extreme – a trailing P/E of 52 versus an industry average of 34 and a price‑to‑book of 45, while the discounted cash‑flow model values the shares near $321, implying a ~‑18% downside from current levels. The dividend yield is modest at 0.42% with a low payout ratio of 19%, supported by ample cash and a net cash position after debt. Recent earnings beat and a Zacks Rank 1 upgrade provide a short‑term catalyst, but analyst coverage remains cautious, with Barclays maintaining an Underweight stance. Overall, the stock appears overvalued, volatile, and exposed to high beta risk, suggesting a measured approach.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with limited upside
  • Bearish MACD signal and decreasing volume
  • Extreme valuation multiples relative to peers

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and high operating margins
  • Continued earnings beat and dividend sustainability
  • Persistent overvaluation and high beta volatility

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • DCF fair value far below market price
  • Low ROE and ROA indicating inefficient capital use
  • High beta and sector volatility amplifying downside risk

Key Metrics & Analysis

Financial Health

Revenue Growth35.80%
Profit Margin29.90%
P/E Ratio51.8
ROE136.08%
ROA46.69%
Debt/Equity11.46
P/B Ratio45.3
Op. Cash Flow$716.3M
Free Cash Flow$516.8M
Industry P/E33.7

Technical Analysis

TrendBullish
RSI58.2
Support$687.71
Resistance$803.47
MA 20$752.03
MA 50$649.87
MA 200$567.44
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value$321.43
Target Price$623.50
Upside/Downside-17.94%
GradeOvervalued
TypeGrowth
Dividend Yield0.42%

Risk Assessment

Beta1.42
Volatility62.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.